Ornithine decarboxylase activity in tissues from rats exposed to 60 Hz magnetic fields, including harmonic and transient field characteristics.

Ornithine decarboxylase (ODC) activity is used widely as a biomarker for tumor promotion in animal model systems. Several previous studies have reported increases in ODC activity in tissues of rats exposed to 60 Hz magnetic fields. The goals of this study were to confirm these findings and to determine whether ODC activity is increased in tissues of animals exposed to magnetic fields containing complex metrics. Three experiments were conducted in male F344 rats. Each study included a sham control group and a group exposed to pure continuous 60 Hz fields (0.2 mT). Additional groups included animals exposed to randomly time-varying 60 Hz fields (range of 0.02 to 0.2 mT); intermittent 60 Hz fields (2 mT) with on-off cycles ranging from 5 s to 5 min; pure continuous 180 Hz fields (2 mT); 60 Hz fields with a superimposed 3rd harmonic (total field strength, 2 mT); 60 Hz fields with superimposed third, fifth, and seventh harmonics (total field strength, 2 mT); 60 Hz fields (2 mT) with superimposed transients; and randomly time-varying 60 Hz fields (range of 0.02 to 0.2 mT) with superimposed transients. After 4 weeks of exposure (18.5 h/day), eight animals per group were euthanized within 1 h of magnetic field deactivation. Homogenates of liver, kidneys, spleen, and brain were prepared from each animal, quick-frozen, and shipped for analysis by four independent laboratories. No consistent pattern of differences in the ODC activity among experimental groups was found either within a laboratory or among laboratories. The results do not support the hypothesis that exposure to extremely low frequency magnetic fields stimulates ODC activity.

Androlaelaps rotundus Fonseca (Acari: Laelapidae) associated with akodontine rodents in Paraguay: a morphometric examination of a pleioxenous ectoparasite

A multivariate analysis of morphometric data suggests that the nominally pleioxenous ectoparasite, Androlaelaps rotundus, includes at least three distinct host-associated populations in Paraguay. Where multiple akodontine hosts occur sympatrically, each host species is accompanied by a morphologically distinct mite population. These host-mite associations were consistent across all localities, implying that A. rotundus is a complex of unrecognized species

Evaluation of in vitro effects of 50 and 60 Hz magnetic fields in regional EMF exposure facilities.

A weak association between magnetic-field exposure and increased incidences of cancer has been reported. While alterations in cellular processes after in vitro magnetic-field exposures have also been reported to provide plausibility for this association, other laboratories have been unable to repeat the findings. As part of an accelerated electric- and magnetic-field (EMF) research program, the National Institute of Environmental Health Sciences with the Department of Energy identified the replication of the published positive effects as a priority. Regional EMF exposure facilities were established to investigate major in vitro effects from the literature. These included effects on gene expression, intracellular calcium, colony growth in soft agar, and ornithine decarboxylase activity. The laboratories that first reported these effects provided experimental protocols, cell lines, and other relevant experiment details. Regional facility studies included sham/sham exposures (no applied field in either chamber) and were done in a blinded fashion to minimize investigator bias. In nearly all experiments, no effects of magnetic-field exposure were found. The effort provided insight into dealing with the difficulty of replication of subtle effects in complex biological systems. Experimental techniques provided some clues for the differences in experimental results between the regional facility and the original investigator. Studies of subtle effects require extraordinary efforts to confirm that the effect can be attributed to the applied exposure.

Exposure to low-frequency electromagnetic fields does not alter HSP70 expression or HSF-HSE binding in HL60 cells.

Environmental exposure to extremely low-frequency electromagnetic fields (ELF EMFs) has been identified as a possible contributor to increased cancer incidence and other diseases. In vitro studies designed to probe for biological mechanisms that might explain such relationships have included several studies of gene expression. While gene expression studies have focused on MYC, effects of ELF EMFs on the expression of beta-actin, histone H2B, beta-tubulin, SRC, FOS and JUN have also been reported. In addition, some investigators have reported both an induction of HSP70 expression and an increase in HSF-HSE binding in HL60 (human promyelocytic leukemia) cells after exposure to a 60 Hz magnetic field. In this study, HL60 cells were exposed to a weak 60 Hz magnetic field (6.3 or 8.0 microT) or to a positive control heat shock (42 or 44 degrees C). While heat shock led to reproducible induction of HSP70 expression and HSF-HSE binding, no significant effect of exposure to ELF EMFs on either of these end points was observed.

Exposure of Daudi cells to low-frequency magnetic fields does not elevate MYC steady-state mRNA levels.

The effect of extremely low-frequency electromagnetic field (ELF EMF) exposures to human health has been widely debated. Epidemiological studies have found a possible correlation between increased cancer incidence and environmental ELF EMF exposures. Results from in vitro studies performed to examine the possible underlying bioeffects of ELF EMFs have varied greatly. Reported effects range from robust and reproducible effects to undetectable. In this study, Daudi cells were exposed to 60 Hz magnetic fields for 20, 40 or 60 min at flux densities of 12.5, 50, 100 or 500 microT. Exposures were performed in the Regional ELF-EMF Exposure Facility (Rockville, MD) to minimize variables that might contribute to a false positive effect. Exposures included sham/sham, exposed/sham or sham/exposed, and were performed with blinding with respect to type of exposure. 12-O-Tetradecanoylphorbol-13-acetate (TPA) treatment was used as a positive control. Total cellular RNA was isolated using a single-step technique. Human MYC expression was measured by northern blot hybridization as an indicator of the responsiveness of Daudi cells to experimental conditions. Beta-2-microglobulin (B2M) expression was measured simultaneously as an internal control. Exposure to a 60 Hz magnetic field did not significantly alter MYC expression in Daudi cells under any of the exposure conditions.

Androlaelaps rotundus Fonseca (Acari: Laelapidae) associated with akodontine rodents in Paraguay: a morphometric examination of a pleioxenous ectoparasite.

A multivariate analysis of morphometric data suggests that the nominally pleioxenous ectoparasite, Androlaelaps rotundus, includes at least three distinct host-associated populations in Paraguay. Where multiple akodontine hosts occur sympatrically, each host species is accompanied by a morphologically distinct mite population. These host-mite associations were consistent across all localities, implying that A. rotundus is a complex of unrecognized species.

Ornithine decarboxylase activity in developing chick embryos after exposure to 60-hertz magnetic fields.

Fertilized white leghorn eggs were exposed to a 4 micro-Tesla (microT) 60 Hz horizontal magnetic field for 15, 18, 23 and 28 h. After exposure to the magnetic field, the embryos were isolated and assayed for ornithine decarboxylase (ODC) activity. ODC activity in magnetic field-exposed embryos was compared to ODC activity in sham-exposed embryos. ODC activity in magnetic field-exposed embryos was not statistically elevated above sham-exposed embryos.

Ornithine decarboxylase activity in L929 cells following exposure to 60 Hz magnetic fields.

To determine whether there is a biological basis for epidemiological studies which suggest an association between exposure to magnetic fields and cancer, we have attempted to replicate earlier findings on cellular enzymes related to cell proliferation. Here we report on an effort to replicate the doubling of ornithine decarboxylase (ODC) activity in L929 murine fibroblasts following exposure to 60 Hz magnetic fields reported by Litovitz et al. Efforts were made to reproduce the methods and exposure conditions used by the original investigators. Positive controls showed that our assay system responded to other known stimuli of ODC activity. We extended the previously reported investigations by testing a number of exposure conditions and other associated variables. Initial results suggested that cells exposed in the original investigators' laboratory demonstrated an enhanced enzyme activity, whereas cells exposed in our laboratory did not. Experiments in our laboratory using the most important elements of the original investigators' exposure system did not demonstrate any enhancement of ODC activity. Finally, a series of magnetic field exposure and sham exposure experiments conducted in the original investigators' laboratory failed to demonstrate an effect of magnetic fields on ODC activity.

MYC mRNA abundance is unchanged in subcultures of HL60 cells exposed to power-line frequency magnetic fields.

Epidemiological data have not demonstrated conclusively that there exists an association between exposure to power-line frequency electric and magnetic fields (EMFs) and cancer. Some laboratory studies performed to investigate possible mechanisms for such an association reported biological effects of EMF exposure, but attempts to confirm some such reports have had mixed success. The most publicized experiments in this regard were studies on the purported EMF-induced increase in MYC expression in HL60 cells. To address the accuracy and reproducibility of this effect, HL60 cells were exposed to 6-microT 60 Hz magnetic fields, and MYC expression was measured. Assay methods and exposure conditions were as close as practical to those of the investigators that originally reported a positive effect. A chemical agent was used to demonstrate that the cells were responsive to a known stimulus and that the experimental system was sufficiently sensitive to detect such a stimulus. The experimental system had sufficiently low basal variability to allow the detection of effects of the magnitude that had been reported previously. Using either cells from a commercial source or cells supplied by the original investigators, no evidence was obtained to support the hypothesis that EMF exposure could induce MYC expression.

Coordinate regulation of collagen II(alpha 1) and H19 expression in immortalized hamster cells.

Loss of tumor suppressor gene function is essential in the multistep progression of cells to neoplasia. Immortalized cells were established by carcinogen treatment of Syrian hamster embryo cells. At early passages, these nontumorigenic cells retained the ability to suppress tumorigenicity in cell hybrids with malignant cells. Upon passage and subcloning of these suppressor-positive (supB+) cells, variant clones that had lost tumor suppressor activity were isolated. These suppressor-negative (supB-) clones remained nontumorigenic. The mRNAs encoding collagen II(alpha 1a), a chondrocyte differentiation marker, and H19, a developmentally controlled gene, were more abundant in supB+ cells than in supB- cells. Nuclear run-on analysis indicated that the transcription of these genes is differentially regulated. Transient transfection experiments revealed that a cis-acting element in the rat collagen II 5' flanking sequences directs differentially regulated transcription. Gel retention analysis demonstrated the presence of a nuclear DNA-binding factor(s) that specifically recognizes a DNA sequence common to both the rat collagen II sequences and the mouse H19 enhancer. In one set of clones, transcriptional regulation could account for differential collagen II and H19 expression in supB+ and supB- cells. In another set of clones, posttranscriptional controls are responsible for the decreased expression of these genes in supB- cells. The emergence of two independent mechanisms that cause differential expression of collagen II and H19 related to tumor suppressor loss suggests that coordinate regulation of these genes, or others regulated by common mechanisms, may be important in tumor suppression.

Down-regulation of cdc2 in senescent human and hamster cells.

Senescent cells fail to respond to serum-induced signals for DNA synthesis. Because a central role for the p34cdc2 protein kinase is postulated in control of the cell cycle, we examined the status of this kinase in senescent cells and other growth-arrested cells. In growing human and Syrian hamster fibroblasts, three 35S-labeled proteins of 34-36 kDa were immunoprecipitated with p34cdc2 antiserum. Only the two slower migrating forms were phosphorylated as determined by 32P labelling. In senescent cells, which failed to incorporate [3H]thymidine, no p34cdc2 protein was synthesized and very little or no cdc2 mRNA was observed. When maintained for 48 h in 0.5% serum, young cells also retained only marginal cdc2 expression. After stimulation of low serum-arrested cells by addition of 10% serum, a time-dependent increase of cdc2 mRNA was observed, whereas serum stimulation of senescent cells did not increase cdc2 mRNA. In contrast to senescent and low serum-arrested cells, cdc2 mRNA was expressed at normal levels in cells partially growth arrested by isoleucine deficiency in G1, by aphidicolin at G1-S, by etoposide in G2, or by Colcemid in the M phase of the cell cycle, indicating that cdc2 down-regulation does not always occur upon growth arrest. Following transfection of a plasmid containing the human CDC2 gene into hamster cells, expression of human cdc2 failed to overcome the block to DNA synthesis in senescent cells. Although p34cdc2 was synthesized in the transfected cells, the multiple phosphorylated forms of the proteins were not observed. Taken together, these data support the concept that a chain of events leads to senescence. While p34cdc2 kinase may be one of the critical elements, other cell cycle controls are also involved.

Protein kinase C gamma expression mimics phorbol ester-induced transcriptional activation of a murine VL30 enhancer element.

Protein kinase C (PKC), a critical component in the regulation of cell growth, is thought to participate in transmitting the signals of certain cell surface receptor activation events to the nucleus. We have previously shown that stable expression of the PKC gamma isoenzyme in NIH 3T3 cells causes altered growth and enhanced tumorigenicity. In this report, we show that transient expression of the PKC gamma isoenzyme can trans-activate a murine VL30 enhancer element in a pattern similar to that of the phorbol ester tumor promoter 12-O-tetradecanoylphorbol-13-acetate. In contrast, ras activation of this element is distinct both quantitatively and qualitatively from PKC gamma and 12-O-tetradecanoylphorbol-13-acetate activation. These results provide direct evidence that PKC is the cellular mediator in the activation of phorbol ester-responsive genes and suggest a mechanism by which abnormal PKC expression might lead to altered growth control by changing the pattern of cellular gene expression.

A nuclear factor that binds to ras-responsive enhancer elements is present in human tumor cells.

The ras protein can be viewed as molecular switches for undetermined signal transduction pathways. We are interested in defining the downstream effectors and targets associated with ras signal transduction. A nuclear target of ras action is the conserved sequence element TGACTCT, which functions as a ras-responsive transcriptional element (RRE). An Mr 120,000 nuclear factor present in transformed murine cells recognizes the RRE. Mutation of the conserved RRE element to the palindromic element AGACTCT created a binding site that is recognized with 5-fold greater affinity by the Mr 120,000 factor. The palindromic element functions as an RRE as determined by transient transfection assays. UV-crosslinking of nuclear factors in human tumor cell lines to the palindromic element revealed that an Mr 120,000 factor that recognized RREs was present in cells that contain activated Ha- or N-ras genes, but not in human tumor cells that lack activated ras. Expression of exogenous activated ras in a human tumor cell line that lacks the oncogene induced the Mr 120,000 factor. The Mr 120,000 factor, which we have termed ras-responsive factor 1, is an intermediate in the signal transduction pathway that links ras to the nucleus and may play a role in the initiation or progression of human tumors containing an activated ras gene.

Transcriptional activation of a conserved sequence element by ras requires a nuclear factor distinct from c-fos or c-jun.

The expression of transforming growth factor beta type 1 mRNA was increased by conditional expression of ras. A 31-base-pair sequence found approximately 420 base pairs upstream of the gene encoding human transforming growth factor beta 1 acted as a ras-responsive enhancer element in transient transfection assays. The human sequence contains the element TGACTCT that also is found in a murine ras-responsive enhancer. Analysis of nuclear factors present in cells stably transformed by ras indicated that both human and murine sequences were recognized by the same nuclear factor. The role of fos and jun in ras transcriptional activation was analyzed in transfection assays using murine elements that contained either TGACTCT or TGAGTAA. These experiments showed that while both elements are activated by fos/jun expression to nearly the same event, only the former element responded to ras. In addition, activation of reporters containing TGACTCT is 6-fold higher by ras than by fos/jun. Gel retention experiments revealed that the nuclear factor present in cells transformed by ras exhibited the same sequence preference as demonstrated in the transient transfection assays. UV-crosslinking experiments identify a protein of apparent molecular mass 120 kDa that recognizes the ras-responsive element. This work identifies a persistent signal transduction pathway that links ras to nuclear transcription and indicates that a 120-kDa protein is a target of this pathway.

ras oncogene activation of a VL30 transcriptional element is linked to transformation.

The activity of a murine VL30 transcriptional element was increased 20-fold in transient assays by coexpression of mutant ras genes. The cis element did not respond to ras in a revertant cell line that was transformation defective. Therefore, ras-dependent alterations in transcription and ras transformation are linked. Deletion analysis of the VL30 long-terminal-repeat U3 region showed that a minimal 53-base-pair segment is required in cis for oncogene activation of transcription. Gel retention assays using a probe that contained the minimal cis element revealed that a unique complex was formed with nuclear proteins prepared from transformed cells. Exonuclease III footprinting and gel retention experiments that used oligonucleotide probes and competitors indicated that two distinct nuclear factors interact with the minimal cis-responsive element. Site-directed deletion of the 5'-proximal binding site (TGACTCT) resulted in a complete loss of ras responsiveness. However, deletion of this site did not affect stimulation by the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA). These data are consistent with the hypothesis that ras and TPA signal transduction mechanisms for transcriptional activation are distinct.